Table 2—

Relative risks of all-cause and CVD mortality associated with the NCEP, NCEP-R, and IDF definitions of the metabolic syndrome in 20,789 men 20–83 years of age from the ACLS

nNo. deaths (CVD)Man-years of follow-upAll-cause mortality
CVD mortality
RR (95% CI)*RR (95% CI)RR (95% CI)*RR (95% CI)
NCEP
    No16,692449 (134)193,7481.00 (ref.)1.00 (ref.)1.00 (ref.)1.00 (ref.)
    Yes4,097183 (79)43,0631.46 (1.23–1.74)1.36 (1.14–1.62)2.03 (1.54–2.69)1.79 (1.35–2.37)
NCEP-R
    No15,194399 (118)177,5151.00 (ref.)1.00 (ref.)1.00 (ref.)1.00 (ref.)
    Yes5,595233 (95)59,2961.41 (1.21–1.67)1.31 (1.11–1.54)1.89 (1.44–2.47)1.67 (1.27–2.19)
IDF
    No14,546385 (112)170,7801.00 (ref.)1.00 (ref.)1.00 (ref.)1.00 (ref.)
    Yes6,243247 (101)66,0301.36 (1.16–1.60)1.26 (1.07–1.49)1.86 (1.42–2.44)1.67 (1.27–2.20)
  • *

    * Adjusted for age and year of examination.

  • Adjusted for age, year of examination, smoking, alcohol consumption, parental history of premature CVD, and possible CVD at baseline.